Kyle Kline - 01 Dec 2025 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Senior Vice President, CFO
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
01 Dec 2025
Transactions value $
-$558,904
Form type
4
Filing time
03 Dec 2025, 20:23:21 UTC
Previous filing
27 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kline Kyle Senior Vice President, CFO VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON /s/ Kelly G. Huller, Attorney-in-Fact 03 Dec 2025 0002080625

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $194K +3.65K $53.14 3.65K 01 Dec 2025 Direct
transaction GMED Class A Common Stock Options Exercise $282K +5K +137.14% $56.43 8.65K 01 Dec 2025 Direct
transaction GMED Class A Common Stock Options Exercise $322K +5K +57.83% $64.44 13.6K 01 Dec 2025 Direct
transaction GMED Class A Common Stock Options Exercise $312K +4.9K +35.88% $63.68 18.5K 01 Dec 2025 Direct
transaction GMED Class A Common Stock Sale -$1.67M -18.5K -100% $90.00 0 01 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -3.65K -72.92% $0.00 1.35K 01 Dec 2025 Class A Common Stock 3.65K $53.14 Direct F2
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -5K -33.33% $0.00 10K 01 Dec 2025 Class A Common Stock 5K $56.43 Direct F3
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -5K -100% $0.00 0 01 Dec 2025 Class A Common Stock 5K $64.44 Direct F4
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -5K -100% $0.00 0 01 Dec 2025 Class A Common Stock 5K $63.68 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person.
F2 These options were granted on March 24, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F3 These options were granted on February 27, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F4 These options were granted on January 25, 2021 and are fully vested.
F5 These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.